A carregar...
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
Regular prophylactic treatment in severe hemophilia should be considered an optimal treatment. There is no general agreement on the optimal prophylaxis regimen, and adherence to prophylaxis is a main challenge due to medical, psychosocial, and cost controversies. Improved approaches in prophylaxis r...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138045/ https://ncbi.nlm.nih.gov/pubmed/27942241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S84597 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|